PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T
In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...
Tag: CD19 CAR-T therapy
POPULAR NEWS
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission